139 related articles for article (PubMed ID: 30193216)
1. Sulfonyl-containing phenyl-pyrrolyl pentane analogues: Novel non-secosteroidal vitamin D receptor modulators with favorable physicochemical properties, pharmacokinetic properties and anti-tumor activity.
Kang ZS; Wang C; Han XL; Wang B; Yuan HL; Hou SY; Hao MX; Du JJ; Li YY; Zhou AW; Zhang C
Eur J Med Chem; 2018 Sep; 157():1174-1191. PubMed ID: 30193216
[TBL] [Abstract][Full Text] [Related]
2. Further Developments of the Phenyl-Pyrrolyl Pentane Series of Nonsteroidal Vitamin D Receptor Modulators as Anticancer Agents.
Hao M; Hou S; Xue L; Yuan H; Zhu L; Wang C; Wang B; Tang C; Zhang C
J Med Chem; 2018 Apr; 61(7):3059-3075. PubMed ID: 29518319
[TBL] [Abstract][Full Text] [Related]
3. Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy.
Ge Z; Hao M; Xu M; Su Z; Kang Z; Xue L; Zhang C
Eur J Med Chem; 2016 Jan; 107():48-62. PubMed ID: 26562542
[TBL] [Abstract][Full Text] [Related]
4. Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton.
Shen W; Xue J; Zhao Z; Zhang C
Eur J Med Chem; 2013 Nov; 69():768-78. PubMed ID: 24099996
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer.
Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
Eur J Med Chem; 2019 Feb; 163():787-803. PubMed ID: 30579121
[TBL] [Abstract][Full Text] [Related]
6. Effects of alkyl side chains and terminal hydrophilicity on vitamin D receptor (VDR) agonistic activity based on the diphenylpentane skeleton.
Misawa T; Yorioka M; Demizu Y; Noguchi-Yachide T; Ohoka N; Kurashima-Kinoshita M; Motoyoshi H; Nojiri H; Kittaka A; Makishima M; Naito M; Kurihara M
Bioorg Med Chem Lett; 2015 Nov; 25(22):5362-6. PubMed ID: 26432035
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of nonsecosteroidal vitamin D
Wang B; Hao M; Zhang C
Bioorg Med Chem Lett; 2017 Mar; 27(6):1428-1436. PubMed ID: 28216405
[TBL] [Abstract][Full Text] [Related]
8. Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs).
Li Y; Zhang S; Zhang J; Hu Z; Xiao Y; Huang J; Dong C; Huang S; Zhou HB
Eur J Med Chem; 2019 Jun; 172():48-61. PubMed ID: 30939353
[TBL] [Abstract][Full Text] [Related]
9. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of hybrid vitamin D receptor agonist/histone deacetylase inhibitors in vitamin D-resistant triple-negative 4T1 breast cancer.
Bijian K; Kaldre D; Wang TT; Su J; Bouttier M; Boucher A; Alaoui-Jamali M; White JH; Gleason JL
J Steroid Biochem Mol Biol; 2018 Mar; 177():135-139. PubMed ID: 28847749
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of p-carborane-based non-secosteroidal vitamin D analogs.
Fujii S; Kano A; Songkram C; Masuno H; Taoda Y; Kawachi E; Hirano T; Tanatani A; Kagechika H
Bioorg Med Chem; 2014 Feb; 22(4):1227-35. PubMed ID: 24486205
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Antifibrosis Activity in Liver of Nonsecosteroidal Vitamin D Receptor Agonists with Phenyl-pyrrolyl Pentane Skeleton.
Wang C; Wang B; Xue L; Kang Z; Hou S; Du J; Zhang C
J Med Chem; 2018 Dec; 61(23):10573-10587. PubMed ID: 30350999
[TBL] [Abstract][Full Text] [Related]
14. Synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition.
Fischer J; Wang TT; Kaldre D; Rochel N; Moras D; White JH; Gleason JL
Chem Biol; 2012 Aug; 19(8):963-71. PubMed ID: 22921063
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel mifepristone derivatives via suppressing KLF5 expression for the treatment of triple-negative breast cancer.
Lin Y; Liu R; Zhao P; Ye J; Zheng Z; Huang J; Zhang Y; Gao Y; Chen H; Liu S; Zhou J; Chen C; Chen H
Eur J Med Chem; 2018 Feb; 146():354-367. PubMed ID: 29407962
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
18. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
19. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
[TBL] [Abstract][Full Text] [Related]
20. N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells.
Prestegui-Martel B; Bermúdez-Lugo JA; Chávez-Blanco A; Dueñas-González A; García-Sánchez JR; Pérez-González OA; Padilla-Martínez II; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Méndez-Luna D; Trujillo-Ferrara J; Correa-Basurto J
J Enzyme Inhib Med Chem; 2016; 31(sup3):140-149. PubMed ID: 27483122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
